Clinical experience of LAM patients who were managed in the Russian Federation

A. Chuchalin (Moscow, Russian Federation)

Source: International Congress 2018 – Russian Speaking Programme 2018: Part II
Session: Russian Speaking Programme 2018: Part II
Session type: Language session
Number: 139

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Chuchalin (Moscow, Russian Federation). Clinical experience of LAM patients who were managed in the Russian Federation. International Congress 2018 – Russian Speaking Programme 2018: Part II

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
European Respiratory Society living guidelines on the management of hospitalized patients with COVID-19
Source: Virtual Congress 2021 – Precision medicine in respiratory infections
Year: 2021


Treatment outcomes of the use of moxifloxacin in management of patients with XDR-TB in Tomsk Oblast of the Russian Federation
Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis
Year: 2008



Tuberculosis treatment outcomes in HIV co-infected patients in Novokuznetsk, Russian Federation
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018


Predictors of severe COVID-19 disease in the inpatient cohort, Russian Federation.
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021

Treatment of sarcoidosis: clinical guidelines of the Russian Respiratory Society
Source: Virtual Congress 2021 – Russian programme 2021
Year: 2021


Management of pneumothorax in a district general hospital comparing with the British Thoracic Society guidelines
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008

European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis
Source: Eur Respir J 2010; 35: 14-26
Year: 2010


Tuberculosis treatment completion in migrants, St.-Petersburg, Russian Federation
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011

Stratification of COPD in primary health care: use of Spanish Society of Pulmonology (SEPAR) and Spanish Society of Community Health Medicine (SEMFYC) guidelines
Source: Eur Respir J 2005; 26: Suppl. 49, 544s
Year: 2005

Risk factors of pneumonia in servicemen of the Russian Federation
Source: Eur Respir J 2005; 26: Suppl. 49, 144s
Year: 2005

Investigation of asthma prevalence in the adolescents of Russian Federation
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011


European Respiratory Society Guidelines for the diagnosis and management of lymphangioleiomyomatosis (LAM)
Source: Guideline 2010
Year: 2010

Epidemiologic situation on TB in penitentiary constitutions of Russian Federation
Source: Annual Congress 2010 - Tuberculosis epidemiology
Year: 2010

“Patients Included” in the European Respiratory Society International Congress
Source: Breathe 2015; 11: 249-254
Year: 2015


Chylothorax: clinical experience in Institute of Phthisiatry and Pulmonology, Ukraine
Source: Eur Respir J 2003; 22: Suppl. 45, 509s
Year: 2003

Compliance to the British Thoracic Society (BTS) guidelines of the investigation and management of pleural effusion in adults: an audit of practice from a general hospital in Ireland
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008


Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease
Source: Eur Respir J 2016; 47:1345-1347
Year: 2016


The risk of default in TB patients in the Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

Effectiveness of national standardized and WHO regimens and risk factors of unfavorable outcomes in treatment of patients with MDR-TB in Novosibirsk Oblast, Russian Federation
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014